We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
Cap. Flow
-$6.04M
Cap. Flow %
-0.54%
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 10.97%
3 Technology 7.15%
4 Communication Services 3.95%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAAAW
326
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$404K 0.04%
+41,111
New +$22.9K
CLBTW
327
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$397K 0.04%
+42,835
New +$98.5K
SNRH
328
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$392K 0.04%
40,150
FSSI
329
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$388K 0.03%
39,700
SOND
330
DELISTED
Sonder
SOND
$387K 0.03%
+1,959
New +$388K
EBAC
331
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$382K 0.03%
+39,500
New +$382K
LITT
332
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$378K 0.03%
+38,802
New +$377K
PFSW
333
DELISTED
PFSweb, Inc.
PFSW
$378K 0.03%
+29,339
New +$367K
BENEU
334
DELISTED
Benessere Capital Acquisition Corp. Unit
BENEU
$373K 0.03%
+34,630
New +$372K
ADEX.WS
335
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$364K 0.03%
37,327
-142
-0.4% -$84
CIIGU
336
DELISTED
CIIG Capital Partners II, Inc. Unit
CIIGU
$352K 0.03%
+34,921
New +$352K
DSAC
337
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
$326K 0.03%
33,300
+6,600
+25% +$64.1K
VTAQU
338
DELISTED
Ventoux CCM Acquisition Corp. Unit
VTAQU
$319K 0.03%
+30,700
New +$319K
EUCR
339
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$313K 0.03%
31,990
-1,100
-3% -$10.7K
FAZE
340
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$305K 0.03%
31,300
RAMMW
341
DELISTED
Aries I Acquisition Corporation
RAMMW
$244K 0.02%
+24,491
New +$17.2K
VEEA
342
Veea Inc
VEEA
$8.59M
$242K 0.02%
25,036
+4,441
+22% +$43.2K
MSAC
343
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$237K 0.02%
24,260
-73,640
-75% -$709K
MOBXW icon
344
Mobix Labs Warrants
MOBXW
$225K 0.02%
+22,875
New +$10.4K
FICVU
345
DELISTED
Frontier Investment Corp Units
FICVU
$224K 0.02%
+22,701
New +$225K
KALV
346
CALL
DELISTED
KalVista Pharmaceuticals
KALV
$175K 0.02%
10,000
CRU
347
DELISTED
Crucible Acquisition Corporation
CRU
$173K 0.02%
17,722
AMPI
348
DELISTED
Advanced Merger Partners Inc
AMPI
$130K 0.01%
13,422
ACKIW
349
DELISTED
Ackrell SPAC Partners I Co Warrants
ACKIW
$116K 0.01%
+11,350
New +$6.39K
VENAR
350
DELISTED
Venus Acquisition Corporation Rights
VENAR
$68K 0.01%
138,480

Similar funds

Mangrove Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.

  • Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
  • Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
  • Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
  • Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
  • Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.